1. Incidence and risk factors of esophagogastric varices bleeding in cirrhotic patients with advanced hepatocellular carcinoma treated with lenvatinib. (March 2023) Authors: Iavarone, M.; Alimenti, E.; Tada, T.; Shimose, S.; Suda, G.; Yoo, C.; Soldà, C.; Piscaglia, F.; Casadei-Gardini, A.; Marra, F.; Vivaldi, C.; Conti, F.; Schirripa, M.; Iwamoto, H.; Sho, T.; Lee, So Heun; Rizzato, M.D.; Tonnini, M.; Rimini, M.; Campani, C. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. N32Denosumab after bone progression with zoledronic acid: a single center experience. (26th September 2015) Authors: Pastorelli, D.; Zovato, S.; Soldà, C. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 6 Page Start: vi Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Total Neoadjuvant Therapy Followed by Surgical Resection: Could it Be the New Standard of Care in Pancreatic Cancer? A Systematic Review. (2022) Authors: De Simoni, O.; Barina, A.; Soldà, C.; Bergamo, F.; Lonardi, S.; Pilati, P.; Gruppo, M. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗